STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

IONS IONIS PHARMACEUTICALS INCORPORATED StockScouter® Report

5

StockScouter® Score

IONIS PHARMACEUTICALS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The 50-day moving average for IONS is above its 200-day moving average. Positive
  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • One or more analysts has significantly decreased quarterly earnings estimates for IONS. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be in favor, growth stocks will be in favor, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 40% done.
Progress: 40% done.
Low
High

Core Model Grades

F
C
D
C

Previous Ratings

6
5
5